Enzo Biochem, Inc. (NYSE:ENZ – Get Rating) was the target of a significant decrease in short interest in May. As of May 31st, there was short interest totalling 1,090,000 shares, a decrease of 8.4% from the May 15th total of 1,190,000 shares. Currently, 3.3% of the shares of the stock are short sold. Based on […]